| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/27/2001 | WO2000041707A3 USE OF $i(LACTOBACILLUS SALIVARIUS) |
| 09/27/2001 | US20010025162 Article having a lotioned topsheet |
| 09/27/2001 | US20010025157 Implantable dispensing device for controllably dispensing medicinal fluid |
| 09/27/2001 | US20010025144 Gas filled liposomes and their use as ultrasonic contrast agents |
| 09/27/2001 | US20010025107 S-lansoprazole compositions and methods |
| 09/27/2001 | US20010025058 Therapy for fungus infections |
| 09/27/2001 | US20010025057 Containing nitric oxide donar containing nitroglycerin, glycol dinitrate, isopropyl nitrate, glyceryl-1,3-dinitrate, glyceryl-1,2-dinitrate, butane-1,2,4-triol-trinitrate, erythrityl teteranitrate, pentaerithrityl tetetranitrate etc. |
| 09/27/2001 | US20010025046 A stabilized self-emulsifying system, comprising a o-(chloroacetylcarbamoyl)fumigillol drug, a carrier which is an oily constituent, a surfactant and a stabilizer; angiogenesis inhibitor |
| 09/27/2001 | US20010025040 Useful for treating allergic rhinitis, vasomotor rhinitis and allergic conjunctivitis; nonsedating antihistamines or salts, leukotriene D4 antagonist or 5-lipoxygenase inhibitor or FLAP protein antagonist |
| 09/27/2001 | US20010025033 Uracil substituted at 5-position by C2-4 alkynyl used as inactivator of uracil reductase enzyme |
| 09/27/2001 | US20010024678 Wrapping film for drugs, cosmetics, foods |
| 09/27/2001 | US20010024666 Composition for and method of reducing low density lipoprotein cholesterol concentration |
| 09/27/2001 | US20010024663 Sustained release dosage form unit having latex coating and method of making the same |
| 09/27/2001 | US20010024660 Drug core sensitive to acidity pH; protective coating of methacrylic acid copolymer |
| 09/27/2001 | US20010024659 Controlled release metformin formulations |
| 09/27/2001 | US20010024658 A delayed release pharmaceutical dosage form for oral administration of heparin comprising a low molecular weight heparin, a bile salt or acid, and a surfactant selected from hydrophilc and lipophilic, and a means for sustained release |
| 09/27/2001 | US20010024657 Comprising an adhesive component that is effective for adhering to teeth or dentures, which comprising a polymer selected from acrylic, acrylate, poly(meth)acrylate, polysacchride, and gums and a nonadhesive component |
| 09/27/2001 | US20010024651 Method for inducing a systemic immune response to an antigen |
| 09/27/2001 | US20010024649 Topical treatment comprises an ester or amide lipophilic molecule capable of traversing the statum corneum and inducing immature dendritic cells to migrat to the draining lymphoid organ |
| 09/27/2001 | US20010024642 A chewing gum that includes a gum center and a coating that substantially surrounds the center, comprises at least 50% by weight of chewing gum, the coating includes medicine; chewing the gum, causes the drug release, in patients buccal cavity |
| 09/27/2001 | US20010024641 Providing particles of at least one active material selected from corticosteroids, beta -agonists, anticholinergics, leukotriene antagonists and inhalable proteins or peptides and a solid binder, agglomerating active particles and binder |
| 09/27/2001 | US20010024639 Administering to a patient a contrast medium comprising a homogenous aqueous suspension of low density polymeric microsphere filled with a gas, scanning the patient using computed tomography imaging to obtain visible image of tissue |
| 09/27/2001 | US20010024637 Novel compositions for use in embolizing blood vessels |
| 09/27/2001 | US20010024636 Thermally reversible stimulus- sensitive gel or gelling copolymer radioisotope carrier that is a linear random copolymer of an (meth)acrylamide derivative and a hydrophil comonomer |
| 09/27/2001 | DE19947681C1 Vorrichtung und Verfahren zur Herstellung wirkungsmodifizierter Allergene Apparatus and method for preparing modified allergens effective |
| 09/27/2001 | DE10108727A1 Plaster for transdermal release of active substance(s) has the substance loaded on a molecular sieve which has been partially dehydrated to reduce its water of crytallisation content |
| 09/27/2001 | DE10050268A1 Dentifrice composition containing hypnotic-sedative agent, to aid sleep in addition to cleaning the teeth |
| 09/27/2001 | DE10013712A1 Nikotinsalze mit verbessertem Geschmack, Verfahren zu ihrer Herstellung und ihre Verwendung Nicotine salts with improved taste, process for their preparation and their use |
| 09/27/2001 | DE10012151A1 Aerosol inhalant containing vitamin A compound in liposomes based on phosphatidylcholine, useful for treatment of tracheo-bronchial illnesses, especially chronic obstructive pulmonary disease |
| 09/27/2001 | CA2404275A1 Cosmetic use of hop and ornithine |
| 09/27/2001 | CA2404112A1 Sustained release delivery systems for solutes |
| 09/27/2001 | CA2404064A1 Stabilized dry powder formulations |
| 09/27/2001 | CA2403818A1 Matrices containing nitric oxide donors and reducing agents and their use |
| 09/27/2001 | CA2403553A1 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors |
| 09/27/2001 | CA2401908A1 Amorphous torasemide modification |
| 09/27/2001 | CA2400118A1 Oxazolidinone tablet formulation |
| 09/27/2001 | CA2400114A1 Container for linezolid intravenous solution |
| 09/27/2001 | CA2399695A1 Pharmaceutical composition for administration to mucosal surfaces |
| 09/27/2001 | CA2399028A1 Use of mia in immunotherapy |
| 09/27/2001 | CA2364272A1 Azeotrope-like compositions of pentafluoropropane and water |
| 09/26/2001 | EP1136487A1 Nicotine salts with improved taste, process for their preparation and use thereof as smoking cessation agents |
| 09/26/2001 | EP1136083A1 Gene therapy for cardiomyopathy |
| 09/26/2001 | EP1136081A1 Sustained-release compositions for the parenteral administration of macrolides |
| 09/26/2001 | EP1136070A1 Soft capsules comprising polymerisates of vinylesters and polyethers, use and preparation thereof |
| 09/26/2001 | EP1136069A1 Pharmaceutical compositions containing clodronates for high local tolerance intramuscular administration |
| 09/26/2001 | EP1136068A2 Powder containing physiologically active peptide |
| 09/26/2001 | EP1136067A1 Oral formulations of medicaments |
| 09/26/2001 | EP1135439A1 Poly(alpha-1,4-d-glucan) and thermoplastic polymer mixtures containing the same |
| 09/26/2001 | EP1135418A1 Biopolymer salts with low endotoxin levels, biopolymer compositions thereof and methods of making the same |
| 09/26/2001 | EP1135397A1 Method for preparation of disodium pamidronate |
| 09/26/2001 | EP1135361A1 Therapeutic product and its use |
| 09/26/2001 | EP1135359A1 Derivatives of (-)-venlafaxine and methods of preparing and using the same |
| 09/26/2001 | EP1135358A1 Derivatives of (+)-venlafaxine and methods of preparing and using the same |
| 09/26/2001 | EP1135193A1 Agents provided for treating tumors, based on liposomes, and containing tamoxifen |
| 09/26/2001 | EP1135182A1 Blood pump without bearing |
| 09/26/2001 | EP1135178A1 Polymeric coatings with controlled delivery active agents |
| 09/26/2001 | EP1135173A1 A medicinal aerosol formulation |
| 09/26/2001 | EP1135163A1 Topical compositions comprising ascomycins |
| 09/26/2001 | EP1135152A1 A pharmaceutical composition comprising cyclosporin in a lipid carrier |
| 09/26/2001 | EP1135150A1 Self-emulsifying compositions for drugs poorly soluble in water |
| 09/26/2001 | EP1135147A2 Method for producing medicaments from plant extracts, in a solid form of administration |
| 09/26/2001 | EP1135139A1 Micronized eplerenone compositions |
| 09/26/2001 | EP1135127A1 New pharmaceutical composition and the process for its preparation |
| 09/26/2001 | EP1135125A1 Controlled-release dosage forms comprising zolpidem or a salt thereof |
| 09/26/2001 | EP1135120A2 Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents |
| 09/26/2001 | EP1135118A1 Dispersible compositions containing l-dopa ethyl ester |
| 09/26/2001 | EP1135112A1 An oral formulation for gastrointestinal drug delivery |
| 09/26/2001 | EP1135111A2 Autoadhesive oral transmucosal delivery dosage form |
| 09/26/2001 | EP1135110A1 Preparation of dry compositions soluble in the presence of water and avoiding maillard reaction in dry state and uses |
| 09/26/2001 | EP1135109A2 Method for producing solid forms of administration by melt extrusion |
| 09/26/2001 | EP1135108A1 Method for producing agglomerates comprising a core-shell structure |
| 09/26/2001 | EP1135107A1 Utilisation of capsules containing one or more antigenic substances for the prevention and/or treatment of autoimmune diseases |
| 09/26/2001 | EP1135106A1 Sustained release matrix systems for highly soluble drugs |
| 09/26/2001 | EP1135105A2 Method for administering agents to the central nervous system |
| 09/26/2001 | EP1135102A1 Cosmetic skin care compositions containing 4-chromanone |
| 09/26/2001 | EP1135101A2 Method for improving uv radiation stability of photosensitive sunscreen filters |
| 09/26/2001 | EP1135092A1 Cleavable solid dosage forms and method for the production thereof |
| 09/26/2001 | EP1135036A1 Smoking products containing antioxidants |
| 09/26/2001 | EP1003499B1 Diclofenac solution for topical application |
| 09/26/2001 | EP0988033B1 Use of dichlorobenzyl alcohol for preparing a preparation for topical treatment of inflammation |
| 09/26/2001 | EP0912239B1 Method for providing dense particle compositions for use in transdermal particle delivery |
| 09/26/2001 | EP0888772B1 Sustained-release metal valproate tablets |
| 09/26/2001 | EP0876142B1 Topical delivery of drugs to the lower gastrointestinal tract |
| 09/26/2001 | EP0839026B1 Polyether block copolymer micellar compositions for targeting biological agents |
| 09/26/2001 | EP0839008B1 Edible products having inorganic coatings |
| 09/26/2001 | EP0825860B1 Use of a composition comprising amoxycillin and clavulanic acid for the manufacture of a medicament for the treatment of bacterial infections in paediatric patients |
| 09/26/2001 | EP0776198B1 Transdermal therapeutic system with protection against hydrolysis |
| 09/26/2001 | EP0735864B1 Method for preparing low dose pharmaceutical products |
| 09/26/2001 | EP0732914B1 Sulfated polyvinyl alcohol polymers to stabilize pharmaceutical drug compounds |
| 09/26/2001 | EP0723436B1 Multiple unit tableted dosage form i |
| 09/26/2001 | EP0706383B1 Compositions for inhalation |
| 09/26/2001 | CN1314900A Particle-formijng compositions containing fused pyrrolocarbazoles |
| 09/26/2001 | CN1314818A Method for administering insulinotropic peptides |
| 09/26/2001 | CN1314810A Perfusate preparation for ophthalmic operation |
| 09/26/2001 | CN1314809A Method of vaccination of newly hatched poultry |
| 09/26/2001 | CN1314804A Improved stability for injection solutions |
| 09/26/2001 | CN1314189A Preparation of high molecular gel stick agent |
| 09/26/2001 | CN1314173A External use plaster for removing poison, alleviating pain and removing necrotic tissue and promoting granulation |
| 09/26/2001 | CN1314170A Medicine for treating diabetes and its preparation process |
| 09/26/2001 | CN1314169A Medicine for treating hepatitis B |